Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non‐small cell lung cancer

Revisions in the International System for Staging Lung Cancer

1997 • 4,582 citations

High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer

2013 • 3,981 citations

Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer

2004 • 2,270 citations

Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.

1999 • 340 citations

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.

1996 • 288 citations

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.

2001 • 272 citations

Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil.

1978 • 181 citations

Expression of angiopoietins and its clinical significance in non-small cell lung cancer.

2002 • 151 citations

Effect of uracil on metabolism of 5-fluorouracil in vitro.

1979 • 141 citations

EDITORIAL. CD105 AND ANGIOGENESIS

1996 • 134 citations

UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.

1999 • 113 citations

Postoperative adjuvant chemotherapy with PVM (Cisplatin+Vindesine+Mitomycin C) and UFT (Uracil+Tegaful) in resected stage I–II NSCLC (non-small cell lung cancer): a randomized clinical trial1

1999 • 83 citations

gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.

2001 • 66 citations

Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer

2001 • 26 citations

UFT and its metabolites inhibit cancer-induced angiogenesis. Via a VEGF-related pathway.

2000 • 12 citations

Postoperative adjuvant therapy for non-small cell lung cancer: a consensus report

1994 • 9 citations

768 Efficacy of oral UFT for adjuvant chemotherapy after complete resection of non-small cell lung cancer: Meta-analysis of six randomized trials in 2003 patients

2003 • 5 citations